Endotherapy Devices Market

By Type;

Gastrointestinal (GI) Devices & Accessories(Biopsy Forceps, Injection Needles, Polypectomy Snares, Graspers, Hemoclips, and Others), Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories(Guide Wire, Sphincterotome, Catheter, Extraction Basket, Extraction Balloon, Balloon Dilation, Plastic Stent, Metal Stents, and Others), Others

By Application;

Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endotherapy, Neuroendoscopy, Gastrointestinal Endoscopy, and Other.

By End-use;

Hospitals, Ambulatory Surgical Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn796768333 Published Date: August, 2025

Endotherapy Devices Market Overview

Endotherapy Devices Market (USD Million)

Endotherapy Devices Market was valued at USD 4,490.16 million in the year 2024. The size of this market is expected to increase to USD 6,445.56 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.


Endotherapy Devices Market

*Market size in USD million

CAGR 5.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.3 %
Market Size (2024)USD 4,490.16 Million
Market Size (2031)USD 6,445.56 Million
Market ConcentrationMedium
Report Pages338
4,490.16
2024
6,445.56
2031

Major Players

  • Stryker
  • Boston Scientific Corporation
  • Fujifilm
  • Conmed Corporation
  • Medtronic
  • Karl Storz
  • Johnson & Johnson Consumer Inc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Endotherapy Devices Market

Fragmented - Highly competitive market without dominant players


The Endotherapy Devices Market is expanding rapidly as healthcare providers adopt specialized minimally invasive instruments for targeted interventions. The market has grown by over 37%, driven by demand for efficient systems supporting biopsy, stent delivery, and tissue ablation. This trend guides strategic deployment, allowing clinics to expand therapeutic capabilities and boost procedural precision.

Smart Technologies Elevate Treatment Accuracy
Emerging technological advancements, such as robot-guided catheters, bioabsorbable scaffolds, and needle-system integration, have led to a 39% rise in device uptake. These solutions deliver fine control, shorter procedure times, and reduced complications. Ongoing innovation in endotherapy design is driving improved clinical practice and solidifying growth in target device adoption.

Modular Solutions Offer Clinical Versatility
Demand for customizable endotherapy systems has increased by 35%, reflecting the need for interchangeable toolbeds, precise control settings, and accessory compatibility. Designed to fit varied procedural demands, these modular platforms foster streamlined workflows. This trend in product innovation is boosting efficiency and sustained growth in interventional care.

AI‑Driven Platforms Setting New Standards
About 43% of endotherapy devices now feature AI‑enhanced targeting, digital image overlays, and connected analytics for procedural guidance. These technological advancements equip clinicians with decision support, real‑time metrics, and safety alerts. The move toward smart device platforms is contributing to the future outlook, enabling scalable market expansion and more reliable intervention results.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End-use
    4. Market Snapshot, By Region
  4. Endotherapy Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Early disease detection boosts demand
        2. Innovations like capsule endoscopy drive market growth
        3. Endoscopic ultrasound adoption rises
        4. Healthcare pros increasingly recognize endotherapy benefits
      2. Restraints
        1. Concerns about post-procedure complications linger
        2. Accessibility issues persist in remote areas
        3. Infection risks with reusable devices pose concerns
      3. Opportunities
        1. Customize devices for specific applications
        2. Develop disposable devices for infection control
        3. Embrace telemedicine for remote care
        4. Diversify into therapeutic endoscopy and surgery
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Endotherapy Devices Market, By Type, 2021 - 2031 (USD Million)
      1. Gastrointestinal (GI) Devices & Accessories
        1. Biopsy Forceps
        2. Injection Needles
        3. Polypectomy Snares
        4. Graspers
        5. Hemoclips
        6. Others
      2. Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories
        1. Guide Wire
        2. Sphincterotome
        3. Catheter
        4. Extraction Basket
        5. Extraction Balloon
        6. Balloon Dilation
        7. Plastic Stent
        8. Metal Stents
        9. Others
      3. Others
    2. Endotherapy Devices Market, By Application, 2021 - 2031 (USD Million)
      1. Bronchoscopy
      2. Arthroscopy
      3. Laparoscopy
      4. Urology endotherapy
      5. Neuroendoscopy
      6. Gastrointestinal endoscopy
      7. Others
    3. Endotherapy Devices Market, By End-use, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Ambulatory Surgical Centers

      3. Others

    4. Endotherapy Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Stryker
      2. Boston Scientific Corporation
      3. Fujifilm
      4. Conmed Corporation
      5. Medtronic
      6. Karl Storz
      7. Johnson & Johnson Consumer Inc.
  7. Analyst Views
  8. Future Outlook of the Market